31/03/2006 (Agence Europe) - On 29 March, the European Commission adopted an implementing regulation organising conditional marketing authorisation for medicines for human use introduced by the reform of European pharmaceutical legislation adopted in March 2004. These conditional authorisations seek to allow the temporary use in emergencies of new medicines to be used to treat seriously debilitating or life-threatening diseases. They must give patients affected a “major therapeutic...